jaythari oral suspension
Generic: deflazacort
Labeler: zydus pharmaceuticals (usa) inc.Drug Facts
Product Profile
Brand Name
jaythari oral suspension
Generic Name
deflazacort
Labeler
zydus pharmaceuticals (usa) inc.
Dosage Form
SUSPENSION
Routes
Active Ingredients
deflazacort 22.75 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
70710-2131
Product ID
70710-2131_726f1539-369c-4fc4-a1fe-059457d26c49
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA220042
Listing Expiration
2026-12-31
Marketing Start
2025-11-20
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
707102131
Hyphenated Format
70710-2131
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
jaythari oral suspension (source: ndc)
Generic Name
deflazacort (source: ndc)
Application Number
ANDA220042 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 22.75 mg/mL
Packaging
- 1 BOTTLE in 1 CARTON (70710-2131-3) / 13 mL in 1 BOTTLE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "726f1539-369c-4fc4-a1fe-059457d26c49", "openfda": {"nui": ["N0000175576", "N0000175450"], "unii": ["KR5YZ6AE4B"], "rxcui": ["1870964", "2727381"], "spl_set_id": ["abf1dba1-cfd8-4a05-aa2b-ffacfbeb9fa9"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (70710-2131-3) / 13 mL in 1 BOTTLE", "package_ndc": "70710-2131-3", "marketing_start_date": "20251120"}], "brand_name": "JAYTHARI Oral Suspension", "product_id": "70710-2131_726f1539-369c-4fc4-a1fe-059457d26c49", "dosage_form": "SUSPENSION", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "70710-2131", "generic_name": "Deflazacort", "labeler_name": "Zydus Pharmaceuticals (USA) Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "JAYTHARI Oral Suspension", "active_ingredients": [{"name": "DEFLAZACORT", "strength": "22.75 mg/mL"}], "application_number": "ANDA220042", "marketing_category": "ANDA", "marketing_start_date": "20251120", "listing_expiration_date": "20261231"}